| Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer U Sahin, E Derhovanessian, M Miller, BP Kloke, P Simon, M Löwer, ... Nature 547 (7662), 222-226, 2017 | 2194 | 2017 |
| S100A8 and S100A9 in inflammation and cancer C Gebhardt, J Németh, P Angel, J Hess Biochemical pharmacology 72 (11), 1622-1631, 2006 | 799 | 2006 |
| Baseline biomarkers for outcome of melanoma patients treated with pembrolizumab B Weide, A Martens, JC Hassel, C Berking, MA Postow, K Bisschop, ... Clinical Cancer Research 22 (22), 5487-5496, 2016 | 574 | 2016 |
| RAGE signaling sustains inflammation and promotes tumor development C Gebhardt, A Riehl, M Durchdewald, J Németh, G Fürstenberger, ... The Journal of experimental medicine 205 (2), 275-285, 2008 | 453 | 2008 |
| Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification task TJ Brinker, A Hekler, AH Enk, J Klode, A Hauschild, C Berking, B Schilling, ... European Journal of Cancer 113, 47-54, 2019 | 442 | 2019 |
| The role of myeloid-derived suppressor cells (MDSC) in cancer progression V Umansky, C Blattner, C Gebhardt, J Utikal Vaccines 4 (4), 36, 2016 | 416 | 2016 |
| Myeloid cells and related chronic inflammatory factors as novel predictive markers in melanoma treatment with ipilimumab C Gebhardt, A Sevko, H Jiang, R Lichtenberger, M Reith, K Tarnanidis, ... Clinical Cancer Research 21 (24), 5453-5459, 2015 | 371 | 2015 |
| Endothelial Notch1 activity facilitates metastasis E Wieland, J Rodriguez-Vita, SS Liebler, C Mogler, I Moll, SE Herberich, ... Cancer cell 31 (3), 355-367, 2017 | 282 | 2017 |
| A convolutional neural network trained with dermoscopic images performed on par with 145 dermatologists in a clinical melanoma image classification task TJ Brinker, A Hekler, AH Enk, J Klode, A Hauschild, C Berking, B Schilling, ... European Journal of Cancer 111, 148-154, 2019 | 253 | 2019 |
| Myeloid cell function in MRP-14 (S100A9) null mice JAR Hobbs, R May, K Tanousis, E McNeill, M Mathies, C Gebhardt, ... Molecular and cellular biology, 2003 | 250 | 2003 |
| Reactive neutrophil responses dependent on the receptor tyrosine kinase c-MET limit cancer immunotherapy N Glodde, T Bald, D van den Boorn-Konijnenberg, K Nakamura, ... Immunity 47 (4), 789-802. e9, 2017 | 237 | 2017 |
| S100A8andS100A9are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis J Németh, I Stein, D Haag, A Riehl, T Longerich, E Horwitz, K Breuhahn, ... Hepatology 50 (4), 1251-1262, 2009 | 180 | 2009 |
| Calgranulins S100A8 and S100A9 are negatively regulated by glucocorticoids in a c-Fos-dependent manner and overexpressed throughout skin carcinogenesis C Gebhardt, U Breitenbach, JP Tuckermann, BT Dittrich, KH Richter, ... Oncogene 21 (27), 4266-4276, 2002 | 179 | 2002 |
| Elevated chronic inflammatory factors and myeloid‐derived suppressor cells indicate poor prognosis in advanced melanoma patients H Jiang, C Gebhardt, L Umansky, P Beckhove, TJ Schulze, J Utikal, ... International journal of cancer 136 (10), 2352-2360, 2015 | 175 | 2015 |
| CCR5+ myeloid-derived suppressor cells are enriched and activated in melanoma lesions C Blattner, V Fleming, R Weber, B Himmelhan, P Altevogt, C Gebhardt, ... Cancer research 78 (1), 157-167, 2018 | 149 | 2018 |
| Tumour hypoxia promotes melanoma growth and metastasis via High Mobility Group Box-1 and M2-like macrophages. FLE Huber R, Meier B, Otsuka A, Fenini G, Satoh T, Gehrke S, Widmer D ... Sci Rep. 6, 29914, 2016 | 130 | 2016 |
| CCR5 in recruitment and activation of myeloid-derived suppressor cells in melanoma V Umansky, C Blattner, C Gebhardt, J Utikal Cancer Immunology, Immunotherapy 66, 1015-1023, 2017 | 83 | 2017 |
| Profile of gene expression induced by the tumour promotor TPA in murine epithelial cells J Schlingemann, J Hess, G Wrobel, U Breitenbach, C Gebhardt, ... International journal of cancer 104 (6), 699-708, 2003 | 81 | 2003 |
| Myeloid-derived suppressor cells and tumor escape from immune surveillance V Umansky, C Blattner, V Fleming, X Hu, C Gebhardt, P Altevogt, J Utikal Seminars in immunopathology 39, 295-305, 2017 | 78 | 2017 |
| Myeloid‐derived suppressor cells in malignant melanoma V Umansky, A Sevko, C Gebhardt, J Utikal JDDG: Journal der Deutschen Dermatologischen Gesellschaft 12 (11), 1021-1027, 2014 | 78 | 2014 |
Jochen Sven Utikal, MDProfessor for Dermatooncology, German Cancer Research Center and University Medical Center MannheimVerified email at dkfz.de
